Healthcare Economist January 10, 2024
Jason Shafrin

Last week, FDA authorized the State of Florida to import pharmaceuticals from Canada. The price of branded pharmaceuticals in Canada is nearly three times the cost of identical pharmaceuticals in the US, so this approach could save the US money.

While there are some administrative issues to work out on the US side, the biggest issue is the following: Canada doesn’t want to sell. CBC reports that Canadian Health Minister Mark Holland stated:

“There is no way we will allow any jurisdiction, be it a state or another foreign jurisdiction, to endanger the Canadian drug supply. That is not an appropriate solution to whatever challenges they may be facing…
We’re going to do everything in our power to make sure...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
Will Trump's healthcare appointments bring 'radical changes'?

Share This Article